Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2006 1
2009 1
2010 3
2011 6
2012 5
2013 5
2014 3
2016 3
2017 5
2018 4
2019 1
2020 7
2021 4
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Ouédraogo A, Bougouma EC, Palacpac NMQ, Houard S, Nebie I, Sawadogo J, Berges GD, Soulama I, Diarra A, Hien D, Ouedraogo AZ, Konaté AT, Kouanda S, Myoui A, Ezoe S, Ishii KJ, Sato T, D'Alessio F, Leroy O, Tiono AB, Cousens S, Horii T, Sirima SB. Ouédraogo A, et al. Front Immunol. 2023 Oct 16;14:1267372. doi: 10.3389/fimmu.2023.1267372. eCollection 2023. Front Immunol. 2023. PMID: 37908361 Free PMC article. Clinical Trial.
Editorial: Puzzle pieces from malaria vaccine clinical trials.
Palacpac NMQ, Tiono AB, Mordmüller B, Tsuboi T. Palacpac NMQ, et al. Front Immunol. 2023 Jan 30;14:1138763. doi: 10.3389/fimmu.2023.1138763. eCollection 2023. Front Immunol. 2023. PMID: 36793714 Free PMC article. No abstract available.
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination.
Arisue N, Palacpac NMQ, Ntege EH, Yeka A, Balikagala B, Kanoi BN, Bougouma EC, Tiono AB, Nebie I, Diarra A, Houard S, D'Alessio F, Leroy O, Sirima SB, Egwang TG, Horii T. Arisue N, et al. Front Cell Infect Microbiol. 2022 Dec 16;12:1058081. doi: 10.3389/fcimb.2022.1058081. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36590593 Free PMC article.
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
Bougouma EC, Palacpac NMQ, Tiono AB, Nebie I, Ouédraogo A, Houard S, Yagi M, Coulibaly SA, Diarra A, Tougan T, Ouedraogo AZ, Soulama I, Arisue N, Yaro JB, D'Alessio F, Leroy O, Cousens S, Horii T, Sirima SB. Bougouma EC, et al. Front Immunol. 2022 Aug 31;13:978591. doi: 10.3389/fimmu.2022.978591. eCollection 2022. Front Immunol. 2022. PMID: 36119062 Free PMC article. Clinical Trial.
Evidence of Artemisinin-Resistant Malaria in Africa.
Balikagala B, Fukuda N, Ikeda M, Katuro OT, Tachibana SI, Yamauchi M, Opio W, Emoto S, Anywar DA, Kimura E, Palacpac NMQ, Odongo-Aginya EI, Ogwang M, Horii T, Mita T. Balikagala B, et al. Among authors: palacpac nmq. N Engl J Med. 2021 Sep 23;385(13):1163-1171. doi: 10.1056/NEJMoa2101746. N Engl J Med. 2021. PMID: 34551228
56 results